Endodontic variables in patients with SARS-CoV-2 infection (COVID-19) in relation to the severity of the disease

Autor: M. Poyato-Borrego, M. León-López, J. Martín-González, JM. Cisneros-Herreros, D. Cabanillas-Balsera, JJ. Segura-Egea

Publikováno v: Medicina Oral Patología Oral y Cirugia Bucal.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68b84d73a7c179da0597409d841443a1
https://doi.org/10.4317/medoral.25773

DI-072 Relationship between the use of carbapenems and the incidence of extended spectrum beta-lactamase producing microorganisms in a tertiary hospital

Autor: María Antonia Pérez-Moreno, R Alma-Marin, JA Lepe-Jiménez, JM Cisneros-Herreros, MV Gil-Navarro, A Garcia-Avello

Publikováno v: Drug information and pharmacotherapy.

Background Extended spectrum beta-lactamases (ESBL) are enzymes produced by gram negative bacilli pathogens (mainly Escherichia coli and Klebsiella pneumoniae ) than confer resistance against penicillins, cephalosporins and aztreonam. Persistent expo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::195b4d833b97934b78bc173dc70ca8dc
https://doi.org/10.1136/ejhpharm-2017-000640.319

CMV Viral Replication Determined by Quantitative PCR and Pp-65 Antigenaemia after Allogeneic Hemopoietic Stem Cell Transplantation (ALO-HSCT)

Autor: Ildefonso Espigado, Pilar Pérez-Romero, Fáti ma de la Cruz Vicente, R. Parody Ruiz-Berdejo, A. Urbano-Ispizua, Jm. Cisneros-Herreros, Manuela Aguilar-Guisado

Publikováno v: Blood. 112:4380-4380

INTRODUCTION: More than 50 % of alo-HSCT recipients develop CMV infection. The best technique for early detection of viral replication has not already been defined. Antigenaemia is the most used technique but it presents limitations. Quantitative RT-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e6d4f8560b19a25359b251daf864abbd
https://doi.org/10.1182/blood.v112.11.4380.4380

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.

Autor: Citarella BW; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Kartsonaki C; MRC Population Health Research Unit, Clinical Trials Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Ibáñez-Prada ED; Universidad de La Sabana, Chía, Colombia.; Clínica Universidad de La Sabana, Chía, Colombia., Gonçalves BP; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Baruch J; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Escher M; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Pritchard MG; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Wei J; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Philippy F; Competence Centre for Methodology and Statistics, Luxembourg Institute of Health, Strassen, Luxembourg., Dagens A; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Hall M; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lee J; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Kutsogiannis DJ; Department of Critical Care Medicine, Faculty of Medicine and Dentistry, The University of Alberta, Edmonton, Alberta, Canada., Wils EJ; Department of Intensive Care, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Fernandes MA; Department of Internal Medicine, Hospital Curry Cabral, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal., Tirupakuzhi Vijayaraghavan BK; Department of Critical Care Medicine, Apollo Hospitals, Chennai, India and The George Institute for Global Health, New Delhi, India., Panda PK; AIIMS, Rishikesh, India., Martin-Loeches I; Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St James' Hospital, Dublin, Ireland., Ohshimo S; Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Fatoni AZ; Department of Anesthesiology and Intensive Therapy, Saiful Anwar General Hospital, Brawijaya University, Malang, East Java, Indonesia., Horby P; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Dunning J; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Rello J; Vall d'Hebrón Institute Research, Barcelona, Spain.; CHU Nîmes, Nîmes, France., Merson L; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Rojek A; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK.; Royal Melbourne Hospital, Melbourne, Australia., Vaillant M; Competence Centre for Methodology and Statistics, Luxembourg Institute of Health, Strassen, Luxembourg., Olliaro P; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Reyes LF; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK.; Universidad de La Sabana, Chía, Colombia.; Clínica Universidad de La Sabana, Chía, Colombia.

Publikováno v: Heliyon [Heliyon] 2024 May 04; Vol. 10 (10), pp. e29591. Date of Electronic Publication: 2024 May 04 (Print Publication: 2024).

Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.

Autor: Griffee MJ; Department of Anesthesiology, University of Utah, Salt Lake City, Utah, USA.; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom., Bozza PT; Laboratory of Immunopharmacology, Institutio Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Reyes LF; Unisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chia, Colombia., Eddington DP; Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA., Rosenberger D; Department of Anesthesiology, University of Zurich, Zürich, Switzerland., Merson L; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom., Citarella BW; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom., Fanning JP; Faculty of Medicine, University of Queensland, Brisbane, Australia., Alexander PMA; Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., Fraser J; Critical Care Research Group, The Prince Charles Hospital, University of Queensland, Brisbane, Australia., Dalton H; Pediatric Critical Care Medicine, Heart and Vascular Institute, Inova Fairfax Hospital, Annandale, Virginia, USA., Cho SM; Divisions of Neuroscience Critical Care and Cardiac Surgery, Departments of Neurology, Surgery, Anesthesia and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2023 Jul 01; Vol. 7 (5), pp. 102142. Date of Electronic Publication: 2023 Jul 01 (Print Publication: 2023).